Physician profile
Thomas P Ragukonis
NPI 1992744312
$6,099.38
in general payments reported to CMS, 2019-2025
7 companies · $2,981 in 2025
The $2,981 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2020: $693 · 2021: $435 · 2024: $865 · 2025: $2,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $3,705 · Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $3,705.37 |
| Food and Beverage | $140.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,840.86 | 2025 | |
| Abbott Laboratories | $1,511.50 | 2019-2020 | |
| Johnson & Johnson Health Care Systems INC. | $864.51 | 2024 | |
| Boston Scientific Corporation | $637.72 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $186.31 | 2021 | |
| Zynex Medical, INC. | $46.64 | 2025 | Nexwave |
| Arbor Pharmaceuticals, INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ragukonis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.